港股升幅擴至近400點 金融地產板塊及三桶油領漲 惟石藥吐6%失10天線
為期兩天的中美高級別經貿磋商正在華盛頓展開，雙方都暗示對達成部分協議持謹慎樂觀態度，加上愛爾蘭總理瓦拉德卡會晤英國首相約翰遜後表示可能於本月31日前達成脫歐協議，投資者對中美貿前景及英國有協議脫歐的樂觀情緒升溫。亞太區股市今早全面跟隨歐美主要市場(普遍升0.6%-1.3%)造好，但升幅均少於1%。
不過，港股繼昨天反覆回穩後，今早高開278點或1.1%報25,986(重越10天線)，升幅曾擴至398點，高見26,106，現造26,082，急漲374點或1.5%，成交額261億元。
藍籌股幾乎全面造好；港交所(00388.HK)、四大內銀、中銀(02388.HK)、中國平安(02318.HK)、匯控(00005.HK)、恆生(00011.HK)及國壽(02628.HK)升逾1%-2%，後三者升幅最大，分別報58.7元/161.2元/18.38元。至於重磅股騰訊(00700.HK)續升1.7%報324.2元。
地產股全面升逾1%；恆隆地產(00101.HK)、長實集團(01113.HK)、新地(00016.HK)及恆地(00012.HK)更升2.2%-2.9%，分別報18元/52元/110.7元/37.05元。
憧憬中美貿易磋商取得成果，紐約期油漲近2%至53.55美元逾一星期高位，「三桶油」股價均重越10天線，中石化(00386.HK)、中石油(00857.HK)及中海油(00883.HK)升2%-3%，分別報4.64元/4.09元/11.84元。此外，創科實業(00669.HK)由兩個低位重越10天線(53.25元)，最高見53.5元，現造53.1元，回升3.1%。煤氣(00003.HK)跑贏公用股，報15.26元，回升2%，結束四連跌。
不過，兩大藥股中生製藥(01177.HK)及石藥(01093.HK)吐1.8%及6%，分別報10.66元及16.04元，後者失守10天線(16.24元)。國家衛生健康委發布「首批鼓勵仿製藥目錄」，其中包括不少緊缺藥品，如甲氨蝶呤、巰嘌呤、維A酸等，共涉及藥品33項。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
